Clinical trial
Dysregulated Tyrosine Kinase Signaling in Leukemia
NCT00277056 · University of New Mexico, Other · Terminated
Key facts
| NCT number | NCT00277056 |
|---|---|
| Title | Dysregulated Tyrosine Kinase Signaling in Leukemia |
| Official title | Dysregulated Tyrosine Kinase Signaling in Leukemia |
| Lead sponsor | University of New Mexico, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Leukemia |
| Enrollment | 30 |
| Start date | May 1, 2002 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Jan 13, 2006 |
| Last update posted | Feb 7, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: